IV. Fajdigovi dnevi KRONIýNA BOLEýINA, SLADKORNA BOLEZEN ...

Medveš�ek M. Prepre�evanje sladkorne bolezni tipa 2
7. Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and
its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation.
Diabet Med 1998; 15: 539-53.
8. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK et al. Predictors of progression from
impaired glucose tolerance to NiDDM: an analysis of six prospective studies. Diabetes 1997; 46: 701-10.
9. Harris MI. Impaired glucose tolerance: prevalence and conversion to NIDDM. Diabet Med 1996; 13 (suppl 2): S9-11.
10. Vegt F, Dekker J, Jager A, Hienkes E, Kostense PJ, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ. Relation of
impaired fasting and postload glucose with incident type 2 diabetes in Dutch population. The Hoorn Stidy. JAMA 2001;
285: 2109-13.
11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: report of the expert committee on the
diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
12. Stern MP, Fatehi P, Williams K, Haffner S. Predicting future cardiovascular dusease. Diabetes Care 2002; 25: 1851-6.
13. Tuomilehto J. Point: a glucose tolerance test is important for clinical practice. Diabetes Care 2002; 25. 1880-1.
14. The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and
cardiovascular mortality: comparison of fasting and 2-hour diagnoatic criteria. Arch Intern med 2001; 161: 397-405.
15. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forham A, Eschwege E. High blood glucose concentration is a
risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris
Prospective Study, and Helsinki Policeman Study. Diabetes Care 1998; 21:360-7.
16. Balkau B, Bertrais S, Ducimetiere P, Eschwege E. Is there a glycemic treshold for mortality risk? Diabetes Care 1999;
22:696-9.
17. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48:937-42.
18. Ohlson L-O, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L et al. The influence of body fat distribution in
relation to incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913.
Diabetes 1985; 34: 1055-8.
19. Folsom AR, Kushi LH, Anderson KE. Associations of general and abdominal obesity with multiple health outcomes in
older women: the Iowa Women's Health Satudy. Arch Intern Med 2000; 160: 2117-8.
20. Kim CK, Newton KM, Knopp RH. Gestational diabetes and the incidence of the type 2 diabetes. Diabetes Care 2002;
25: 18623-8.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third
National Health and Nutrition Examination Survey. JAMA. 2002; 287:356-359.
22. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonlureas or insulin compared with
conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-
53.
23. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:412-9.
24. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the
development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl Med J
1993;329:977-86.
25. Okhubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyosyi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin
therapy prevents the progression of diabetic microvascular complications in Japanise patients with non-insulin–
dependent diabetes mellitus: a randomisezed prospective 6-yr sudy. Diabetes Res Clin Pract 1995; 28: 103-7.
26. Cutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a
metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care
1999; 22:233-40.
27. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Subclinical states of glucose tolerance and risk of death in the U. S.
Diabetes Care 2001; 24: 447-53.
28. Uusitupa MIJ. Early intervention in patients with non-insulin-dependent diabetes and impaired glucose tolerance. Ann
Med 1996; 28: 445-9.
29. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin resistant prediabetic subjects have more atherogenic
risk factors than insulin sensitive prediabetic subjects: implications for preventing coronary heart disease during the
prediabetic state. Circulation 2000; 101: 975-80.
30. UK Perspective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular
complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-13.
31. Pyorälä K, Pedersen TR, Kjekshus J, et al. Chlolesterol lowering with simvastatin improves prognosis of diabetic
patients with coronary heart disease: a subgroup analysis of the Scandinavian Survival Study (4S). Diabets Care 1997;
20: 614-20.
32. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular
events and death with pravstatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
N Engl J Med 1998; 339: 1349-57.
33. Golberg RB, Mellies MJ, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and
glucose-intolerant myocardial infarction survivirs with average cholesterol levels. Subgroup analyses in the cholesterol
recurrent events (CARE) trial. Circulation 1998; 98:2513-19.
34. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a
randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
35. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR. Risk factors for coronary artery
disease in non-insulin dependent diabetes mellitus (UKPDS 23). BMJ 1998; 316: 823-8.
4. Fajdigovi dnevi, Kranjska Gora, 11. – 12. 10. 2002 23